Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT05742867
Eligibility Criteria:
Inclusion Criteria:
* Must reside in Japan and able to speak/read Japanese for the interview/survey
* Must have a clinical diagnosis of Muscle-invasive bladder cancer (MIBC):
* ypT2-ypT4a or ypN+ MIBC, with prior neoadjuvant cisplatin chemotherapy and underwent radical cystectomy
* pT3-pT4a or pN+ MIBC, without prior neoadjuvant cisplatin chemotherapy and underwent radical cystectomy
* Must not have received any treatment related to MIBC after radical cystectomy
Exclusion Criteria:
* Determined by the physician as being unsuitable for the study (e.g. having any clinically significant psychiatric disorder, cognitive impairment, or having difficulty with communicating in Japanese)
* Confirmed diagnosis of other primary cancers at the time of obtaining consent
* Current participation in a MIBC clinical trial
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05742867
Study Brief:
Protocol Section:
NCT05742867